FDA to address hormone therapy drug label concerns

The FDA says warning labels on some hormone therapy drugs have deterred women who might benefit from receiving menopause treatment. Now, the agency is taking steps it says will make the medicines more accessible. FOX News reporter Mike Emanuel has more.

Trump announces price cuts on Wegovy, Zepbound

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity treatments Zepbound and Wegovy. Here’s what we know.

Shortage of sexual assault nurse examiners across the U.S.

There is a shortage of sexual assault nurse examiners (SANEs), who are crucial in helping survivors get the justice and high-quality care they deserve. FOX 10's Ashlie Rodriguez takes a deeper look into the reasons for the shortage.